Cone Bioproducts Of Seguin, LLC
- UEI
- M1HTKQFCVA73
- CAGE
- 7C3G0
- Primary NAICS
- 325413 In-Vitro Diagnostic Substance Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- conebio.com
- Founded
- 1970
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | -$5,905 |
| FY2023 | -$106,510 |
Contract awards
Quick answers
Is Cone Bioproducts Of Seguin, LLC registered in SAM.gov?
Cone Bioproducts Of Seguin, LLC's SAM.gov registration expired on May 22, 2024.
What is Cone Bioproducts Of Seguin, LLC's most recent federal award?
Cone Bioproducts Of Seguin, LLC's most recent federal contract award is Defibrinated plasma from vaccinated subjects (75A50123P00007), from Office of the Assistant Secretary for Preparedness and Response, on May 31, 2023.
On GovTribe
See Cone Bioproducts Of Seguin, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors